[
    [
        {
            "time": "2019-01-01",
            "original_text": "前诺华中国区总裁徐海瑛，上任哈药总经理",
            "features": {
                "keywords": [
                    "诺华",
                    "中国区总裁",
                    "哈药",
                    "总经理"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "前诺华中国区总裁徐海瑛，上任哈药总经理",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-01-01",
            "original_text": "重新审视中国医药市场 2019年国内外药企高层人事调整频繁",
            "features": {
                "keywords": [
                    "医药市场",
                    "人事调整",
                    "2019年"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "重新审视中国医药市场 2019年国内外药企高层人事调整频繁",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "2019-01-01",
            "original_text": "上市至今暴涨10倍！医药并购之王！可股价狂跌56%，又是啥情况？",
            "features": {
                "keywords": [
                    "暴涨",
                    "医药并购",
                    "股价狂跌"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上市至今暴涨10倍！医药并购之王！可股价狂跌56%，又是啥情况？",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-01-01",
            "original_text": "科创板、A股其他板块与港股市场IPO制度及定价估值体系对比分析——会议纪要",
            "features": {
                "keywords": [
                    "科创板",
                    "IPO制度",
                    "定价估值"
                ],
                "sentiment_score": 0.4,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "科创板、A股其他板块与港股市场IPO制度及定价估值体系对比分析——会议纪要",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "2019-01-01",
            "original_text": "【晨会聚焦】银行股大行情的历史梳理：美好时光还会再现？",
            "features": {
                "keywords": [
                    "银行股",
                    "历史梳理",
                    "大行情"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【晨会聚焦】银行股大行情的历史梳理：美好时光还会再现？",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        },
        {
            "time": "2019-03-04",
            "original_text": "【医药】江琦、赵磊：科创板专题报告：丰富医药创新企业上市路径，创新引领未来-20190304",
            "features": {
                "keywords": [
                    "科创板",
                    "医药创新",
                    "上市路径",
                    "创新引领未来"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药】江琦、赵磊：科创板专题报告：丰富医药创新企业上市路径，创新引领未来-20190304",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2019-01-01",
            "original_text": "医药生物行业周报:受益MSCI扩容,板块估值修复有望延续",
            "features": {
                "keywords": [
                    "医药生物",
                    "MSCI扩容",
                    "估值修复"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业周报:受益MSCI扩容,板块估值修复有望延续",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]